MedPath

Mycobacteria Registry Study: Prospective Observational Study in Austria

Recruiting
Conditions
Non-Tuberculous Mycobacterial Pneumonia
Tuberculosis
Registration Number
NCT06522347
Lead Sponsor
Ludwig Boltzmann Institute for Lung Health
Brief Summary

The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is:

What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria?

Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection
  • individuals aged 18 years or older
  • written informed consent
Exclusion Criteria
  • to not comprehend and rightfully judge participation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality30 years

Mortality due to tuberculosis or NTM infection in Austria

Secondary Outcome Measures
NameTimeMethod
Patient cohort30 years

Description of the patient cohort

Prevalence30 years

Prevalence of mycobacterial infections in Austria

Risk factors30 years

Identification of risk factors for treatment failure and complications

Trial Locations

Locations (3)

Klinik Penzing

🇦🇹

Vienna, Austria

Klinik Hietzing

🇦🇹

Vienna, Austria

Ludwig Boltzmann Institut for Lung Health

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath